Vimarsana
Biggest News Aggregation in the World

Page 2 - Sharon Cunningham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sharon Cunningham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sharon Cunningham Today - Breaking & Trending Today

FDA Accepts NDA for SH-201 in Leukemia and Other Cancers - Vimarsana News

FDA Accepts NDA for SH-201 in Leukemia and Other Cancers

The FDA has accepted for review the new drug application for SH-201 for the treatment of patients with certain forms of leukemia and other cancers.

24 tech start-ups to watch in 2024 - Vimarsana News

24 tech start-ups to watch in 2024

Here are some start-ups from all over the world that are ones to watch in 2024, including some big players in AI, health and climate-tech.

SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer - Vimarsana News

SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer

The FDA has announced that it had accepted the new drug application for SH-105 for the treatment of patients with breast and ovarian cancer.

Shorla Oncology and Eversana announce US launch of first oral methotrexate solution - Vimarsana News

Shorla Oncology and Eversana announce US launch of first oral methotrexate solution

Irish pharmaceutical company Shorla Oncology and consultancy firm Eversana have announced the U.S. launch of JYLAMVO, the first oral methotrexate solution.

Jylamvo, an FDA-Approved Oral Solution Formulation of Methotrexate, Now Available - Vimarsana News

Jylamvo, an FDA-Approved Oral Solution Formulation of Methotrexate, Now Available

Jylamvo, an FDA-approved oral solution formulation of methotrexate, is now available from Shorla Oncology and Eversana.